What Mozarc Medical does

Mozarc Medical is a Minneapolis-based medical device company established in April 2023 through equal investments from DaVita, Inc. and Medtronic plc to consolidate kidney health technology assets. The company markets a comprehensive kidney care portfolio spanning three categories: dialysis access (chronic and acute hemodialysis catheters such as Palindrome™ Precision, Mahurkar, Argyle, and Ritus, plus the DKutting PTA scoring balloon), chronic dialysis therapies (Flexya™ hemodialysis system, Clearum™ HS dialyzer with proprietary PES/PVP membrane, bloodlines, and concentrates), and acute extracorporeal therapies (the Carpediem™ cardio-renal pediatric CRRT system for infants 2.5–10 kg, the AMPLYA™ multitherapeutic platform, and Microplas™ plasmafilters). It also distributes the Fujifilm-manufactured iViz air wireless ultrasound in Japan for vascular access management.

The company operates four regional headquarters — Minneapolis (Americas), Mirandola, Italy (EMEA), Tokyo (Asia Pacific), and Shanghai (Greater China) — with dedicated customer care centers serving Mexico, Japan, China, and EMEA. In the US, it sells through more than 30 dedicated field representatives providing hands-on procedural support, complemented by distribution agreements with Cardinal Health, Concordance, Henry Schein, Medline, and Owens and Minor. Revenue is generated from capital equipment sales (dialysis machines, CRRT systems, ultrasound), recurring consumables (dialyzers, bloodlines, catheters, concentrates), and service/maintenance contracts under quote-based B2B pricing.

Mozarc operates as a privately held joint venture with governance ties to both parents: CEO Ven Manda is a 30-year Medtronic veteran who previously led Medtronic Renal Care Solutions; the board is chaired by James Corbett and includes DaVita CFO Joel Ackerman, Medtronic executives Dave Anderson and Laura Mauri, and independent director Kim Lody. On October 28, 2024, Mozarc assumed vendor management of the Medtronic Renal Care Solutions dialysis access product portfolio for US customers, fully separating its ordering systems from Medtronic.

Name

Mozarc Medical

Legal name

Mozarc Medical Holdings LLC

Website

https://mozarcmedical.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

251–500 employees

Short description

Mozarc Medical is a Minneapolis-headquartered medical device joint venture between DaVita and Medtronic, founded in 2023 to develop and sell kidney health technologies — including dialysis catheters, dialyzers, chronic hemodialysis systems, and acute CRRT platforms like Carpediem — to hospitals, dialysis centers, and ICUs across the Americas, EMEA, Japan, and Greater China.

Ownership category

akta.pro rank

Product category

Renal Care Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Dialyzers (Artificial Kidneys) (HLAHAKAC)

akta.pro secondary industry

Home Dialysis Equipment & Remote Monitoring (HLAHAKAG)

Keywords

• Kidney dialysis devices
• Hemodialysis systems
• Dialysis access catheters
• Renal care medical devices
• Peritoneal dialysis catheters

Headquarters

HQ city

Minneapolis

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Device Hardware Sales: Sale of capital equipment including dialysis machines (Carpediem™ System for pediatric acute care, AMPLYA Acute Multitherapeutic System, Flexya Hemodialysis System), dialysis catheters (Palindrome™ Precision, Mahurkar™ Elite, Mahurkar™ Chronic Carbothane™, Argyle™ Peritoneal Dialysis Catheters), and related durable equipment.
2. Consumables and Disposables: Recurring revenue from consumable products including dialyzers (Clearum™ HS), bloodlines, dialysate solutions, catheter kits, accessories, and replacement parts required for ongoing dialysis treatments.
3. Service and Support: Equipment services including maintenance plans, technical support, 24/7 clinical support hotline, and training services for medical professionals.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Mozarc Medical develops, manufactures, and commercializes medical devices dedicated to kidney health. Its portfolio spans chronic and acute hemodialysis catheters, peritoneal dialysis catheters, dialysis systems, dialyzers, PTA scoring balloons, and a pediatric cardio-renal emergency dialysis machine, sold to hospitals, dialysis centers, and neonatal/pediatric intensive care units worldwide.

Product overview

Mozarc Medical offers a comprehensive, holistic portfolio of kidney health technology solutions organized into three main categories: Dialysis Access and Maintenance (including chronic hemodialysis catheters like Palindrome Precision and Mahurkar Carbothane, peritoneal dialysis catheters like Argyle and Ritus, acute hemodialysis catheters like Mahurkar Elite, and vascular maintenance products like DKutting PTA Scoring Balloon), Chronic Dialysis Therapies (including the Flexya Hemodialysis System, Clearum HS Dialyzer, and various consumables and concentrates), and Acute Extracorporeal Blood Treatment Therapies (including the Carpediem pediatric dialysis system, AMPLYA Acute Multitherapeutic System, and supporting consumables). The company also offers advanced therapies (SUPRA HFR, SUPRA AEQUILIBRIUM, MID-DILUTION) and region-specific products like the iViz air ultrasound device in Japan. This is a multi-product medical device portfolio, not a single unified software platform.

Differentiator

Problem solved

Functional benefit

Brands

• iViz air: Wireless ultrasound imaging device
• Carpediem
• Clearum HS
• Palindrome Precision
• Mahurkar
• Argyle
• Ritus
• AMPLYA
• Flexya
• DKutting
• AmeCath
• Microplas
• Solucart

Products and services

• Carpediem Cardio-Renal Pediatric Dialysis Emergency Machine

Quantifiable outcome

• 97% neonate survival rate upon discontinuation of Carpediem™ treatment

Named customers3 records

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Five partnerships are on record, tiered core.

• Cardinal HealthcoreChannel Partner/ Reseller/ DistributorMajor US healthcare distribution partner for Mozarc Medical dialysis access products. Cardinal Health is one of the largest distributors of medical supplies and pharmaceuticals in the United States.
• Concordance Healthcare SolutionscoreChannel Partner/ Reseller/ DistributorUS healthcare distribution partner for Mozarc Medical products, providing logistics and supply chain services for dialysis access products.
• Henry ScheincoreChannel Partner/ Reseller/ DistributorMajor US healthcare distribution partner for Mozarc Medical dialysis access products. Henry Schein is a large distributor of healthcare products and services to office-based dental and medical practitioners.
• MedlinecoreChannel Partner/ Reseller/ DistributorUS healthcare distribution partner for Mozarc Medical products, providing supply chain and distribution services for dialysis and medical supplies.
• Owens and MinorcoreChannel Partner/ Reseller/ DistributorUS healthcare distribution partner for Mozarc Medical products, specializing in medical supply distribution and logistics services.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Fresenius Medical Care: World's largest integrated dialysis products and services company, manufacturing dialyzers, HD machines, and PD products while operating the largest global network of dialysis clinics. Most direct competitor to Mozarc's device portfolio and the dominant player Mozarc must displace in hospital and clinic purchasing decisions.
• Baxter International: Global medical device and pharmaceutical company with a substantial renal care business including dialyzers, CRRT systems (PrisMax), HD machines, and PD solutions. Competes directly with Mozarc across acute (CRRT) and chronic dialysis product lines globally.
• B. Braun Medical: German medical device manufacturer with a significant dialysis and CRRT business (Dialog+, OmniCrit lines) competing in acute and chronic hemodialysis markets worldwide. Particularly strong in EMEA where Mozarc also operates its Mirandola regional HQ.

Emerging players

• Outset Medical: Medical device company that developed the Tablo Hemodialysis System, a modern cartridge-based HD platform targeting both in-center and home dialysis. Represents a newer-generation competitive threat to Mozarc's Flexya HD system with simpler cartridge-based workflow and stronger home dialysis positioning.
• Quanta Dialysis Technologies: UK-based medical device company developing the SC+ hemodialysis system as a compact, portable HD platform for both in-center and home use. Emerging competitive threat in the same chronic HD category where Mozarc offers Flexya, particularly in European and select US accounts.
• Medivators (Cantel Medical): Dialysis water purification and disinfectant systems provider serving dialysis centers. Partial overlap with Mozarc's Dialyclean and H2OClean ultrafilter product line for dialysis water treatment consumables.

Regional players

• Nikkiso: Japanese industrial and medical company with a dialysis equipment division producing HD machines and dialyzers primarily serving APAC markets. Direct overlap with Mozarc's APAC product portfolio (Flexya, AMPLYA, Clearum) in the Japanese and broader Asian dialysis markets.
• Asahi Kasei Medical: Japanese chemical and medical device manufacturer producing dialysis-related products including dialyzers and plasmafilters, with strong APAC market presence. Competes with Mozarc's Clearum HS dialyzer and Microplas plasmafilter product lines, particularly in Japan and Greater China where Mozarc has regional HQs.
• Toray Medical: Japanese manufacturer specializing in dialyzers and artificial kidney products using proprietary membrane technologies. Direct competitor to Mozarc's Clearum HS dialyzer with strong penetration in APAC renal care markets where Mozarc also competes.

Broad incumbents

• Terumo Corporation: Japanese global medical device manufacturer with diversified portfolio including blood management, vascular access, and dialysis-related products. Adjacent competitor in vascular access and blood circuit components that overlap with Mozarc's catheter and bloodline consumables.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/mozarcmedical

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mozarc Medical